Olympus Gains FDA Clearance for POWERSEAL Open Device
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEALâ„¢ Open...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
WESTBOROUGH, MASSACHUSETTS, April 28, 2026 Olympus Corporation has received FDA 510(k) clearance for its latest innovation, the POWERSEALâ„¢ Open...
BESANÇON, France, March 24, 2026 Pixee Medical has announced the U.S. launch of its Knee+ NexSight augmented reality (AR)...
ATLANTA, Feb. 23, 2026 — MiRus announced U.S. FDA 510(k) clearance and commercial launch of the IO™ Expandable Wedge...
Paris and Tampa, Fla., Jan. 13, 2026 — SafeHeal®, a clinical-stage medical device innovator in colorectal surgery, announced the...
RAHWAY, N.J. — December 3, 2025 — Mexico’s Secretariat of Agriculture and Rural Development (SADER) has granted approval for...
Minneapolis, MN — December 3, 2025 — Medtronic announced that the U.S. Food and Drug Administration (FDA) has granted...
